nase and adaptors ATG13 and FIP200, is required for autophagy but is not required for LAP [4, 5] . Also the lipid kinase VPS34, acting in a complex with Beclin1 and ATG14, is important for autophagy initiation, but ATG14 is not required for LAP, and instead a different adaptor, Rubicon, functions as part of a LAP-specific complex [6] . An additional LAP-specific role for NADPH oxidase-2 (NOX2) has also been defined [6, 7] . By leveraging mouse models of deficiency for core autophagy genes versus LAP-specific, or autophagyspecific genes, Martinez et al. were able to identify an important LAP function in immunity [3] .
The authors found that the deletion of core autophagy or LAP-specific genes (Atg5, Atg7, Beclin1 (Becn), Rubicon (Rubcn) and Nox2) from immune cells (macrophages, monocytes, and some neutrophils and dendritic cells), by lysozyme M (LysM)-Cre-mediated gene deletion, led to the development of autoimmune disease. Mice displayed reduced body weight, accumulation of circulating lymphocytes, monocytes, neutrophils, and activated CD8 + T cells, increased proliferation in spleen, and developed autoantibodies (including anti-double-stranded DNA and nuclear antibodies) commonly associated with SLE. They also exhibited signs of kidney damage, with increased expression of IFN signature genes reported in SLE patients. By contrast, mice with immune cell deficiency in Fip200 or Ulk1, which are required for autophagy but not LAP, appeared normal.
What could go wrong in LAPdeficient immune cells to cause SLE? The authors examined whether a failure to degrade engulfed apoptotic cells, a defect reported in LAP-deficient macrophages [2, 5] , could be blamed. Indeed, while deficiency of Atg7 or Rubcn had no observable effect on apoptotic cell engulfment, the degradation of engulfed cells was inhibited in multiple tissues (spleen, liver, kidney) compared to wild-type and Fip200-deficient animals. Moreover, Rubcn -/-mice challenged with repeated apoptotic cell injections over 8-weeks developed more rapid SLE-like hallmarks than controls, including circulating autoantibodies and kidney damage.
The authors further examined cytokine production in the context of LAP deficiency. When challenged with apoptotic cells in culture, LAPproficient but autophagy-deficient macrophages (Cre + Fip200 f/f and Cre
) responded normally by producing anti-inflammatory IL-10, and did not produce pro-inflammatory cytokines (IL-1β, IL-6 and CXCL-10). On the other hand, LAP-deficient macrophages (
) failed to generate IL-10 and secreted high levels of IL-1β, IL-6 and CXCL-10. Similarly in vivo, in response to apoptotic cell injections, pro-inflammatory cytokines were elevated in the serum of LAP-deficient (
), compared to LAP-proficient (wild-type and Cre + Fip200 f/f ) mice, which displayed elevated levels of IL-10. The authors further found that spontaneous cytokine levels from unchallenged mice were altered in all LAP-deficient genotypes upon aging, with reduced IL-10, and elevated levels of a panel of pro-inflammatory cytokines (IL-1β, IL-6, IL-12p40, IP-10, CXCL1, MIP-1β, and MCP-1) that were absent from LAP-proficient mice.
These observations altogether support a model that pro-inflammatory cytokine secretion in response to apoptotic cell ingestion contributes to autoimmune disease in LAP-deficient mice.
The findings by Martinez and colleagues identify an important physiologic function for LAP acting as a protector against autoimmunity ( Figure  1 ), which is a major step forward for this autophagy-related field. Mice with LAP-deficient immune cells develop autoimmune disease similarly to those rendered defective in apoptotic cell engulfment due to deletion of the phagocytosis receptor Tim4 [8] . How a failure to digest engulfed cells leads to development of the hallmarks of SLE, including the production of autoantibodies, is an important question for further study. While LAP inhibition primarily affects corpse degradation acutely, whether persistent corpses could also have broader effects on phagocyte function in the longer term, as has been shown in Drosophila [9] , may be interesting to consider.
Previously LAP was shown to be required for retinoid recycling by phagocytic retinal pigment epithelial cells, which contributes to maintaining vision in mice [10] , and LAP-like LC3 lipidation also occurs on macropinosomes [5] , and at the ruffled border in osteoclasts [11] , suggesting that LAP may contribute significantly to physiology in multiple contexts. In their study, Martinez and colleagues leveraged previous work identifying numerous genes required for LAP versus autophagy to build, by correlation, a compelling model of LAP function in vivo [5] [6] [7] .
While LAP is implicated convincingly by the authors' work, whether any other noncanonical forms of autophagy, potentially involving autophagosomal structures, could contribute to the observed effects is an important question for consideration. Finally, while LC3 lipidation onto phagosomes is a defining feature of the LAP field, the molecular mechanism of LC3 function at phagosomes remains elusive. LC3 is a member of three related families of proteins that participate in autophagy [12] , and multiple members are found at LAPosomes [6] . While LC3 proteins are speculated to control lysosome fusion to phagosomes, their mechanism(s) of action will be important to identify. 
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